LD-2 disclosure · 1st Quarter - Report
INNOVATIVE VACCINE TECHNOLOGIES
Income$60Kfee reported
Client
- Description
- Bio tech company
- Location
- Utah · United States of America
Registrant
- Description
- Government and Public Relations consultants
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
1 issueMedical/Disease Research/Clinical Labs
H.R. 2471 - Consolidated Appropriations Act, 2022 FY 2022 appropriations for the development of a synthetic vaccine
LobbyistsPAUL CAMBON · ROBERT L LIVINGSTON · J ALLEN MARTIN · BRIAN GLACKIN
TargetedSENATE · HOUSE OF REPRESENTATIVES · Defense, Dept of (DOD)